F/M Emerald Life Sciences Innovation ETF (LFSC)

Assets	$89.95M
Expense Ratio	0.54%
PE Ratio	n/a
Shares Out	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	n/a
Open	n/a
Previous Close	37.61
Day's Range	n/a
52-Week Low	18.78
52-Week High	37.99
Beta	n/a
Holdings	38
Inception Date	Oct 31, 2024

About LFSC

Fund Home Page

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: LFSC
• ETF Provider: F/m Investments

Top 10 Holdings

50.82% of assets

Name	Symbol	Weight
Cogent Biosciences, Inc.	COGT	10.09%
LivaNova PLC	LIVN	6.48%
Travere Therapeutics, Inc.	TVTX	5.49%
Guardant Health, Inc.	GH	5.39%
TransMedics Group, Inc.	TMDX	5.19%
Madrigal Pharmaceuticals, Inc.	MDGL	4.32%
BridgeBio Pharma, Inc.	BBIO	4.02%
Savara Inc.	SVRA	3.39%
Corcept Therapeutics Incorporated	CORT	3.34%
Nektar Therapeutics	NKTR	3.11%

Performance

LFSC had a total return of 42.78% in the past year, including dividends. Since the fund's inception, the average annual return has been 46.89%.